Showing results (271-280 of 651) with videos related to

Sort By:
Pageof 66
Diabetes Care|August 23, 2022
Dapagliflozin Improves the Urinary Proteomic Kidney-Risk Classifier CKD273 in Type 2 Diabetes with Albuminuria: A Randomized Clinical TrialViktor Rotbain Curovic, Mie Klessen Eickhoff, Teemu Rönkkö, et al.
Diabetes, Obesity & Metabolism|August 13, 2025
Targeting visceral and ectopic adiposity: Pharmacological and surgical interventions beyond global weight lossMustafa Guldan, Lasin Ozbek, Sama M Abdel-Rahman, et al.
Frontiers in Molecular Biosciences|September 19, 2023
Endotrophin as a risk marker of mortality and kidney complications in a type 1 diabetes cohortAlexandra Louise Møller, Ninna Hahn Tougaard, Daniel Guldager Kring Rasmussen, et al.
Diabetes, Obesity & Metabolism|November 18, 2018
Prevalence of heart failure and the diagnostic value of MR-proANP in outpatients with type 2 diabetesJesper Jensen, Morten Schou, Caroline Kistorp, et al.
Diabetes Care|November 2, 2011
Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rateChristel Joergensen, Henrik Reinhard, Anne Schmedes, et al.
Diabetes Care|March 18, 2008
Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathyTri Q Nguyen, Lise Tarnow, Anders Jorsal, et al.
European Journal of Heart Failure|January 17, 2025
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by diuretic use: A FIDELITY analysisRobert J Mentz, Stefan D Anker, Bertram Pitt, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 12, 2020
Visit-to-visit variability of clinical risk markers in relation to long-term complications in type 1 diabetesViktor Rotbain Curovic, Simone Theilade, Signe Abitz Winther, et al.
Diabetes Care|December 19, 2015
Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical TrialMelanie J Davies, Stephen C Bain, Stephen L Atkin, et al.
Diabetes & Vascular Disease Research|May 19, 2016
Early myocardial impairment in type 1 diabetes patients without known heart disease assessed with tissue Doppler echocardiography: The Thousand & 1 studyMagnus Thorsten Jensen, Peter Sogaard, Henrik Ullits Andersen, et al.
Pageof 66